Leadership Change at Carl Zeiss Meditec: Bronwyn Brophy O’Connor to Become New CEO
Bronwyn Brophy O’Connor takes over the leadership of the Jena-based medical technology group Carl Zeiss Meditec AG, succeeding Maximilian Foerst.
Carl Zeiss Meditec
Leadership Change in Jena: Bronwyn Brophy O’Connor to Become New CEO at Carl Zeiss Meditec
Bronwyn Brophy O’Connor is set to take over the chairmanship of the executive board at Carl Zeiss Meditec AG in Jena, succeeding Maximilian Foerst. The group faces significant challenges, including a global cost-cutting program.
Carl Zeiss Meditec announces worldwide reduction of 1,000 jobs
The Jena-based medical technology company Carl Zeiss Meditec is planning extensive personnel cuts. As the company announced on Tuesday, 1,000 jobs are to be cut worldwide.
Profit Slump at Carl Zeiss Meditec: Job Cuts Planned in Jena
Jena, May 12, 2026 – Following a significant slump in profits, the medical technology group Carl Zeiss Meditec has announced an extensive austerity program. This will include global job cuts, which will also affect the traditional location in Jena.
Carl Zeiss Meditec: 1,000 positions worldwide under review
Jena, May 12, 2026. The Jena-based medical technology group Carl Zeiss Meditec is planning a comprehensive cost-cutting program. Around 1,000 jobs worldwide are under review, triggered by ongoing economic difficulties in the Asian market.
Loss at Carl Zeiss Meditec: Jena-based Traditional Group Feels Headwinds from China
Carl Zeiss Meditec AG reports a quarterly loss of 4.9 million euros. Weak sales in China and currency effects are weighing on the Jena-based medical technology specialist.
Economy in Jena: Carl Zeiss Meditec reports weak start to the year
Carl Zeiss Meditec AG has reported a subdued start to the current fiscal year. For the technology hub of Jena, where the company is deeply rooted, these developments are of significant importance for the local economy and labor market.
Red Alert in ‘Optics Valley’: Carl Zeiss Meditec Reports Losses – China Changes the Rules of the Game
Carl Zeiss Meditec reports a loss of 4.9 million euros in the first quarter. The main reasons are changes in the Chinese market and currency effects. The company is now planning a strategic realignment.
Carl Zeiss Meditec in the Red: China Business Pushes Jena-based Group into Losses
Med-tech giant Carl Zeiss Meditec reports a quarterly loss of 4.9 million euros due to challenges in the Chinese market. The Jena-based company is now weighing a production shift to Asia as it adjusts its financial forecast.
Carl Zeiss Meditec Reports Loss: What Does the China Crisis Mean for Jena?
Carl Zeiss Meditec has slipped into the red, reporting a €4.9 million loss in its first fiscal quarter. As currency fluctuations and shifting procurement rules in China impact the MDAX-listed company, questions arise about the future of its headquarters in Jena. With a strategic pivot toward local production in China looming, the medical technology giant faces a challenging year of transformation.